Showing results (151-160 of 5,003) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|May 29, 2019
Clinical Features of Rituximab-associated Gastrointestinal ToxicitiesNiharika Mallepally, Hamzah Abu-Sbeih, Osman Ahmed, et al.
American Journal of Clinical Oncology|February 1, 1987
Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trialR T Eagan, T M Therneau, J Rubin, et al.
American Journal of Clinical Oncology|June 1, 1986
Phase II study of idarubicin in advanced cervical carcinomaT B Hakes, J B Dougherty, V Raymond
American Journal of Clinical Oncology|October 10, 2021
Treatment and Prevention of Brain Metastases in Small Cell Lung CancerRebekah Rittberg, Shantanu Banerji, Julian O Kim, et al.
American Journal of Clinical Oncology|March 23, 2022
Cardiovascular Diseases Following Breast Cancer: Towards a Case-by-Case Assessment Through a Prediction Risk Score Model in 943 PatientsBenoite Mery, Elise Rowinski, Charlène Rivier, et al.
American Journal of Clinical Oncology|January 24, 2022
Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative ChemotherapyErin N McAndrew, Hanbo Zhang, Pascal Lambert, et al.
American Journal of Clinical Oncology|April 26, 2019
Small Cell Carcinoma of the Esophagus: A Nationwide Analysis of Treatment and Outcome at Patient Level in Locoregional DiseasePaul M Jeene, Elisabeth D Geijsen, Christina T Muijs, et al.
American Journal of Clinical Oncology|June 11, 1999
Phase II trial of topotecan in advanced breast cancer: a Cancer and Leukemia Group B studyE G Levine, C T Cirrincione, T P Szatrowski, et al.
American Journal of Clinical Oncology|June 11, 1999
Bulky, barrel-shaped cervical carcinoma (stages IB, IIA, IIB): the prognostic factors for pelvic control and treatment outcomeH K Kim, B Silver, R Berkowitz, et al.
American Journal of Clinical Oncology|June 11, 1999
Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small-cell lung cancerD J Adelstein, T W Rice, L A Rybicki, et al.
Pageof 501